NASDAQ · MDLNHealthcareSurgical Instruments

Medline Inc. Class A common stock (MDLN)

$40.35+18.36%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$40.35▼ 1.59% in range
Dec 17, 2025Low $31.64 · High $49.99Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Medline closed at $40.35 on Nov 4, up 18.36%, 19.3% below its highest close since Dec 17. Volume of 25.5M shares was 2.88× its 20-day average (well above normal).

Split-adjusted performance: +13.5% over one month, -4.0% over six months.

In the quarter ended Jun 27, 2026, revenue was $7.68B, with a net margin of 0.8%.

Short interest was 40.8M shares at the Oct 15 settlement, down 22.5% from the prior report (13.2% of float, 5.4 days to cover).

Market cap$35.40B877.4M shares
Revenue · quarter$7.68B—
Diluted EPS$0.07—
P/E · TTM—
Net margin0.8%Gross 28.8%
Dividend yieldNone
Range since Dec 1731.64 – 49.99−19.3% from high
Volume25.5M2.88× 20-day avg
Volatility · 60d49.1%Annualised
Short % of float13.2%5.4 days to cover
Net cash-$9.90BCash $2.68B
Next earnings—Not scheduled
Split-adjusted performance
1W +24.7%1M +13.5%3M +16.9%6M −4.0%YTD −3.9%1Y —3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum50
Revenue growth—
Net margin63
Value (low P/E)—
Size96

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short40.8M−22.5% vs prior
Days to cover5.4Settled Oct 15
% of float13.2%
Short vol. 10d39.5%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
MDLNMedline$40.35+18.36%−4.0%—0.8%—$35.40B
RMDResMed$240.51+5.91%+14.7%+5.9%29.6%21.2$33.83BCompare
DXCMDexCom$88.48+6.64%+46.6%+11.2%20.5%33.3$33.00BCompare
WSTWest Pharmaceutical Services$408.78+0.44%+30.8%+8.7%24.5%44.6$28.48BCompare
BDXBecton, Dickinson and$209.19+5.56%+44.5%+5.4%7.6%60.6$56.98BCompare
BSXBoston Scientific$45.82+5.33%−18.2%+1.4%11.3%19.0$66.40BCompare
SOLVSolventum$89.35+5.42%+25.9%+2.2%4.2%10.6$15.21BCompare
GKOSGlaukos$246.70+5.86%+82.4%+58.0%1.0%—$14.60BCompare
BAXBaxter International$26.50+3.96%+56.1%+5.0%9.9%—$13.71BCompare

Quick answers

What does Medline do?
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems.
What is MDLN's market cap?
$35.40B, based on the Nov 4 close of $40.35.
Does Medline pay a dividend?
No regular cash dividend has been paid in the last year.
How much of MDLN is sold short?
40.8M shares, 13.2% of float, as of Oct 15, 2026.
What sector is MDLN in?
Healthcare, in the Surgical Instruments industry.

About Medline

Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.

HQ: Northfield, IL45,000 employeesListed Dec 17, 2025medline.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology